# Lansoprazole

## Takepron Intravenous 30mg

| TAH Drug Code      | [**ITAK**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ITAK)                                                                                                                                            |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | As an alternative to oral therapy when oral intake is not appropriate for GERD in patients with esophagitis &/or severe symptoms of reflux & for healing of gastric ulcers associated with NSAID therapy.           |
| Dosing             | 30 mg IV once or twice daily infusion over 30 minutes.                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                       |
| Contraindications  | Hypersensitivity to Lansoprazole.                                                                                                                                                                                   |
| Adverse Effects    | Headache, abdominal pain, diarrhea, flatulence, nausea/vomiting, constipation. Abnormal hepatic function tests, hyperbilirubinemia, increased serum alkaline phosphatase, increased serum ALT, increased serum AST. |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data â€“ Potential Toxicity(Mother)                                                                                                                                                                |

## Takepron OD 30mg

| TAH Drug Code      | [**OTAK**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OTAK)                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Gastric & duodenal ulcer, reflux esophagitis & Zollinger-Ellison syndrome. In combination of antibiotics to treat H. pylori related peptic ulcer.                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | OD tab Gastric & duodenal ulcer, Zollinger-Ellison syndrome 30 mg once daily for 6 weeks in gastric ulcer & 8 weeks in duodenal ulcer. Reflux esophagitis 30 mg once daily for 8 weeks. Maintenance: 15 mg once daily. May adjust to 30 mg once daily is desired result is not achieved. Adjunct to eradication of H. pylori associated with gastric ulcer or duodenal ulcer lansoprazole 30 mg bid, amoxycillin 750 mg (potency) bid & clarithromycin 200 mg (potency) bid for 7 days. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Hypersensitivity reactions. Rarely, hematological changes; severe hepatic dysfunction with jaundice & enzyme changes; Lyell syndrome, Stevens-Johnson syndrome, interstitial pneumonia. Gastrointestinal: Abdominal pain (up to 5% ), Constipation (1% to 5% ), Diarrhea (up to 7.4% ), Nausea (1.3% to 3% ) Neurologic: Headache Other: Fatigue                                                                                                                                        |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                            |

